Related Experiment Video
Updated: Mar 19, 2026

07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.6K
RUNX3 defines disease behavior in pancreatic ductal adenocarcinoma
Martin C Whittle1, Sunil R Hingorani2
1Clinical Research Division , Seattle, WA.
Molecular & Cellular Oncology
|June 17, 2016
Abstract:
Runt-related transcription factor 3 (RUNX3) functions downstream of transforming growth factor beta (TGFβ) and plays dual roles in pancreas cancer by both suppressing (by inhibiting proliferation) and promoting (by enhancing migratory and metastatic capacity) disease progression. Consideration of the contextual regulation of RUNX3 together with its myriad downstream effects may help improve clinical outcomes for pancreas cancer patients.

